Correction: Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter clinical study

by Takahiro WakasakiI, Tomomi Manako, Ryuji YasumatsuI, Hirotaka Hara, Satoshi Toh, Muneyuki Masuda, Moriyasu YamauchiID, Yuichiro Kuratomi, Emi Nishimura, Toranoshin Takeuchi, Mioko Matsuo, Rina Jiromaru, Kazuki Hashimoto, Noritaka Komune, Takashi Nakagawa